InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Phone+1-857-4536553
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees36
OptionableNot Optionable
InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions
What is InspireMD's stock symbol?
InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."
When did InspireMD's stock split? How did InspireMD's stock split work?
Shares of InspireMD reverse split on Thursday, February 8th 2018. The 1-35 reverse split was announced on Wednesday, February 7th 2018. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 7th 2018. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 3 shares after the split.
How were InspireMD's earnings last quarter?
InspireMD Inc (NYSEAMERICAN:NSPR) issued its quarterly earnings data on Tuesday, November, 6th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $0.77 million for the quarter. View InspireMD's Earnings History.
When is InspireMD's next earnings date?
Has InspireMD been receiving favorable news coverage?
Media stories about NSPR stock have trended very positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InspireMD earned a media sentiment score of 3.2 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Are investors shorting InspireMD?
InspireMD saw a decrease in short interest in December. As of December 31st, there was short interest totalling 1,380,239 shares, a decrease of 26.2% from the December 14th total of 1,869,651 shares. Based on an average daily volume of 732,618 shares, the days-to-cover ratio is currently 1.9 days. Currently, 3.9% of the shares of the stock are short sold. View InspireMD's Current Options Chain.
Who are some of InspireMD's key competitors?
Some companies that are related to InspireMD include Bioquell (BQE), Consort Medical (CSRT), Corindus Vascular Robotics (CVRS), Deltex Medical Group (DEMG), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), LiDCO Group (LID), Lucid (LCDX), Medaphor Group (MED), Smith & Nephew (SN), Theralase Technologies (TLT), Verisante Technology (VRS) and Zecotek Photonics (ZMS).
Who are InspireMD's key executives?
InspireMD's management team includes the folowing people:
- Dr. James J. Barry, Pres, CEO & Director (Age 60)
- Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
- Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
- Dr. Sol J. Barer, Special Advisor to the Board (Age 72)
- Mr. Benzi Spector, Head of R&D and Operations
Who are InspireMD's major shareholders?
InspireMD's stock is owned by many different of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.77%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester. View Institutional Ownership Trends for InspireMD.
Which major investors are buying InspireMD stock?
How do I buy shares of InspireMD?
Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is InspireMD's stock price today?
One share of NSPR stock can currently be purchased for approximately $0.19.
How big of a company is InspireMD?
InspireMD has a market capitalization of $7.14 million. InspireMD employs 36 workers across the globe.
What is InspireMD's official website?
How can I contact InspireMD?
InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.
MarketBeat Community Rating for InspireMD (NYSEAMERICAN NSPR)
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days.
